Accreditation in the Philippines

Size: px
Start display at page:

Download "Accreditation in the Philippines"

Transcription

1 2015/LSIF/FOR/014 Accreditation in the Philippines Submitted by: Philippines 2 nd APEC Blood Supply Chain Policy Forum Anaheim, United States 23 October 2015

2 3/11/2015 ACCREDITATION in THE PHILIPPINES ENSURING THE QUALITY of BLOOD SERVICES APEC AABB FORUM, ANAHEIM, CA 23 0CT0BER 2015 eyarcellananuquiapec eyarcellananuquimdwbdd2015 1

3 NVBSP: MANDATORY SCREENING HIV-1 and HIV-2: screening for both HIV antigen and antibody, or in combination Hepatitis B: screening for hepatitis B surface antigen (HBsAg) Hepatitis C: screening for either a combination of HCV antigen/antibody or HCV antibodies Syphilis (Treponema pallidum): screening for specific treponemal antibodies. eyarcellana-nuqui,mdapec NATIONAL VOLUNTARY BLOOD SERVICES PROGRAM, DEPARTMENT OF HEALTH FIVE MANDATORY TTIs : MALARIA ADDED NUCLEIC ACID TESTING IN SELECTED BLOOD SERVICES NAT UNDER STUDY BY TECHNICAL COMMITTEE FOR INCLUSION IN TESTING ALGORITHM FOR ALL BLOOD CENTERS IN 2016 NAT IMMINENT IN PHILIPPINE RED CROSS BLOOD CENTERS eyarcellananuquiapec

4 QUALITY ASSURANCE FRAMEWORK UNIVERSITY OF THE PHILIPPINES - NATIONAL INSTITUTES OF HEALTH - HILTON LAM, PhD et.al QAF FOR NATIONAL BLOOD SERVICES EYARCELLANA-NUQUI,mdAPEC2015 Quality Assurance Framework (QAF) Objectivity, Impartiality Staff development and training Support from Central Office Sound Financial Management Respecting privacy, Confidentiality Objectivity, Impartiality Quality NVBSP Blood eyarcellananuquiapec

5 Strengthening the Quality assurance framework of the NVBSP eyarcellananuquiapec QAF TOOLS Documentation and monitoring A) Product definition B) Product standardization C) Process documentation D) Equipment maintenance E) Donor satisfaction F) Patient satisfaction G) Hospital satisfaction H) Staff development eyarcellananuquiapec

6 QAF TOOLS : EVALUATION A) Internal time series benchmarks B) External benchmarks C) Identification of good practices D) Adjustment policies (innovations) eyarcellananuquiapec QAF TOOLS: BRANDING OR CONFORMITY A) Centers of excellence B) ISO certification C) JCI Accreditation D) WHO Seal E) NVBSP Seal F) Excellence awards G) Leadership awards eyarcellananuquiapec

7 Philippine Data: HIV per region 1984 to present 16,516 cases reported 2% 2 3.4% 4 HIV CONFIRMED CASES FROM BLOOD DONATIONS DISTRIBUTION PER REGION 2013 STATISTICS. 54% 63 2%(4a) 2 23% 27 5% % % 12 eyarcellananuquimdapec2015 HIV GEOGRAPHIC DISTRIBUTION AS OF APRIL 2015 eyarcellananuquimdwbdd2015 6

8 900 DISTRIBUTION OF POSITIVE BLOOD UNITS BY TYPE OF DONOR Directed Replacement No Data HBV HCV HIV SYP EYARCELLANANUQUI,MDmay2015 NCBS TECHNICAL COMMITTEE REVIEW OF TESTING ALGORITHMS FOR TTIs IMPLEMENTATION OF TECHNICAL STANDARDS UPDATES ON PRODUCT CERTIFICATION STRENGTHENING NEQAS / EQAS CONTINUING PROFESSIONAL EDUCATION, TQM EYARCELLANA-NUQUI,MD2015 7

9 NCBS TECHNICAL COMMITTEE EVIDENCE-BASED EVALUATION AND ADVICE ACTIVE PARTICIPATION IN TECHNICAL WORKING GROUPS / GLOBAL FUND PROJECTS RESEARCH ON VALIDATION OF NON-REACTIVES EYARCELLANA-NUQUI,MD2015 VALIDATION OF NON-REACTIVES QUALITY STATUS SURVEY (WHO) QUALITY ASSURANCE FRAMEWORK STUDY (HILTON LAM et al) NEQAS BY NRL-TTI, RITM EYARCELLANANUQUI,mdAPEC2015 8

10 Validation using Nucleic Acid Testing (NAT) of results of blood donor samples found to be nonreactive to transfusion-transmissible viruses by Immunoassays (EIA/CLIA) RHODA T. YU, RMT Medical Technologist IV Supervisor Transfusion Transmissible Infections National Reference Laboratory (TTI-NRL) eyarcellananuquiapec TTI CONFIRMED POSITIVE BLOOD UNITS Donation Frequency , , New Donors Repeat Donors Total 356 eyarcellananuquiapec2015 HCV HBV HIV 18 9

11 RITM NRL TTI 2014 TTI CONFIRMED POSITIVE BLOOD UNITS 51% Repeat Donors Several Years Ago(2-34 yrs) After a Year Ago < a year ago (2-11 months) No Data HCV HBV HIV eyarcellananuquiapec RITM PRELIMINARY RESULTS FINAL STATUS FREQUENCY PERCENTAGE NEGATIVE % POSITIVE (NAT HBV and EIA HBV) % POSITIVE (EIA HBV only) % POSITIVE (NAT HBV only) % NOT TESTED* % TOTAL: % *Not Tested (Spilled QNS No Sample Old Sample) 10

12 ACCREDITATION in the PHILIPPINES PHILIPPINE ACCREDITATION OFFICE / BUREAU ISO JOINT COMMISSION ON ACCREDITATION (JCI) COLLEGE OF AMERICAN PATHOLOGISTS (CAP) AABB? eyarcellananuquiapec MAJOR CONSTRAINTS THE COSTS OF ACCREDITATION THE COSTS OF EXTERNAL QUALITY ASSURANCE PROGRAMS LIMITED FUNDING FOR NATIONAL REFERENCE LABORATORY UPHEAVALS IN ORGANIZATIONAL STRUCTURE CHANGES IN POLICY DIRECTION STRATEGIC PLANNING AND IMPLEMENTATION NETWORKING LIMITATIONS OF GEOGRAPHY, TOPOGRAPHY eyarcellananuquiapec

13 ISSUES /CHALLENGES ANNUAL BUDGET FOR NEQAS, ANNUAL BUDGET FOR NEGATIVE VALIDATION REGULAR PROFICIENCY TRAINING NATIONAL REFERENCE LABORATORY TTI REVIEW OF TESTING ALGORITHMS GOOD DATA, ACCURATE DATA (NBBNETS, IBBIS) EYARCELLANANUQUI,mdAPEC2015 APEC AABB FORUM 23 OCTOBER 2015 ANAHEIM, CALIFORNIA, USA THANK YOU! MARAMING SALAMAT! MUCHAS GRACIAS! Elizabeth Arcellana-Nuqui, MD National Council for Blood Services, Philippines eyarcellananuquiapec

2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies

2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies 2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies Submitted by: Malaysia Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply Chain Manila, Philippines 30 September 1

More information

Structure and duties of Blood service

Structure and duties of Blood service NATIONAL CENTER FOR TRANSFUSION MEDICINE Prevalence of infectious diseases among Mongolian blood donors Namjil Erdenebayar General director of The National Center for Transfusion Medicine, Mongolia NCTM,

More information

BLOOD SAFETY STATUS IN INDONESIA. Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine

BLOOD SAFETY STATUS IN INDONESIA. Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine BLOOD SAFETY STATUS IN INDONESIA Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine OUTLINE Background Blood services in Indonesia Regulation related to blood safety in Indonesia

More information

Study of ChLIA and ELISA for TTI Markers in Blood Donors

Study of ChLIA and ELISA for TTI Markers in Blood Donors Study of ChLIA and ELISA for TTI Markers in Blood Donors Presenting Author - Miss Kiran Kachhadiya (Co-authors: Dr. Vachhani N., Mrs. Bhatt J, Dr. Jani F., Dr. Nandani S.) Life Blood Centre (Formerly known

More information

Il ruolo delle VEQ per la sicurezza trasfusionale

Il ruolo delle VEQ per la sicurezza trasfusionale Il ruolo delle VEQ per la sicurezza trasfusionale The role of EQA for transfusion safety Giulio Pisani CNCF Ist. Sup. Sanità Global Blood Product Safety, Roma 10 aprile 2019 Blood transfusion is an essential

More information

Screening Donated Blood for Transfusion Transmissible Infections in Bangladesh

Screening Donated Blood for Transfusion Transmissible Infections in Bangladesh Screening Donated Blood for Transfusion Transmissible Infections in Bangladesh National Guidelines 2013 Foreword Mandatory screening of donated blood for transfusion in Bangladesh began in 2000 after implementation

More information

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen Screening donors and donations for transfusion transmissible infectious agents Alan Kitchen Aim Not to teach you microbiology To provide and awareness of the big picture To provide an understanding of

More information

2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience

2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience 2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience Submitted by: Philippines 2 nd APEC Blood Supply Chain Policy Forum Anaheim, United States 23 October

More information

Impact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013

Impact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013 Impact of Testing Strategies to Reduce Transmission Risk for HBV Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013 Overview of SANBS SANBS is a private not for profit company

More information

The Counselling of Blood Donors Identified as HIV Reactive. A Review as from January 2007 until June 2011

The Counselling of Blood Donors Identified as HIV Reactive. A Review as from January 2007 until June 2011 The Counselling of Blood Donors Identified as HIV Reactive A Review as from January 2007 until June 2011 The Blood Transfusion Service of Namibia Dr. Regine Redecker Mr. Tinus Matyayi 2 3 Background -TTI

More information

Guide to the preparation, use and quality assurance of blood components

Guide to the preparation, use and quality assurance of blood components Contents Foreword...3 Members of the European Committee (Partial Agreement) on Blood Transfusion... 8 Members of the GTS working group... 22 Members of the TS066 working group... 30 Recommendation No.

More information

2015/LSIF/FOR/001. Program. Submitted by: United States

2015/LSIF/FOR/001. Program. Submitted by: United States 2015/LSIF/FOR/001 Program Submitted by: United States 2 nd APEC Blood Supply Chain Policy Forum Anaheim, United States 23 October 2015 Day Zero 29 September Location: New World Hotel, Gallery I 2 nd APEC

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Ministry of Health: Institute for Transplantation and Biomedicine / Colour key VIRAL HIV 1 and HIV 2 Hepatitis B Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More

More information

2014/LSIF/PD/008 Building Blocks and Challenges to Implementing a National Blood Program in Malaysia

2014/LSIF/PD/008 Building Blocks and Challenges to Implementing a National Blood Program in Malaysia 2014/LSIF/PD/008 Building Blocks and Challenges to Implementing a National Blood Program in Malaysia Submitted by: Malaysia Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply

More information

Laboratory diagnostics of blood-borne infections related to blood transfusions and transplantations

Laboratory diagnostics of blood-borne infections related to blood transfusions and transplantations 26 th Symposium Croatian Society of Medical Biochemistry and Laboratory Medicine Laboratory diagnostics of blood-borne infections related to blood transfusions and transplantations Croatian Institute of

More information

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on

More information

QSEAL Recovered Plasma Specification

QSEAL Recovered Plasma Specification QSEAL Recovered Plasma Specification Background The is part of a series of standards that comprise the Plasma Protein Therapeutics Association (PPTA) QSEAL Standards Program. PPTA's Voluntary Standards

More information

Database on Blood Safety 2009 in ECO Member States

Database on Blood Safety 2009 in ECO Member States Database on Blood Safety 2009 in ECO Member States Section 1: Administrative Information Information provided by: 1.1 Name: 1.2 Title: 1.3 Position: 1.4 Organization: 1.5 Address: 1.6 Country: 1.7 Tel.

More information

The establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas

The establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas Blood Safety Global Database on Blood Safety (GDBS) 2013 The World Health Organization (WHO) programme on Blood Transfusion Safety would appreciate your kind cooperation in completing this data collection

More information

Blood Donor Counselling

Blood Donor Counselling Blood Donor Counselling A presentation for the Nepal Red Cross Society Blood Transfusion Service Dr Che Kit Lin On behalf of GAP and Hong Kong Red Cross 26 th August 2014 Purpose and Outcomes of Workshop

More information

Donor Screening in The Region. Vincini GA NRL, Melbourne, Australia

Donor Screening in The Region. Vincini GA NRL, Melbourne, Australia Donor Screening in The Region Vincini GA NRL, Melbourne, Australia NRL Established in 1985 Not-for-profit organisation that exists to support laboratories that perform testing for the diagnosis and management

More information

Demographic profile of syphilis among blood donors at a tertiary care hospital

Demographic profile of syphilis among blood donors at a tertiary care hospital ORIGINAL ARTICLE Demographic profile of syphilis among blood donors at a tertiary care hospital Yesha Shah 1,Farzana Kothari 3, Milind Dighe 2, Chirag Chaudhari 4 1 2nd Year Resident in Immunohaematology

More information

HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS. Joana Bikulčienė Director of National blood center

HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS. Joana Bikulčienė Director of National blood center HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS Joana Bikulčienė Director of National blood center j.bikulciene@kraujodonoryste.lt Organizational structure of Lithuanian blood service 1 specialized

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legally binding More stringent - recommended Not legally binding and not recommended Non-reproductive tissues and cells

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Tested pathogen Donor test/ technique

More information

Transfusion Medicine in Saudi Arabia

Transfusion Medicine in Saudi Arabia Transfusion Medicine in audi Arabia, Mc, FRCPath, CTM Director of Blood Transfusion ervices Associate Professor in Haematology KAUH, Jeddah, audi Arabia Total Area1,960,582.00 sq Population27,019,731 (2006

More information

Viral Hepatitis in Blood Donors

Viral Hepatitis in Blood Donors Viral Hepatitis in Blood Donors VHPB country meeting Prof Asc.Vjollca Durro Microbiology Service Medicine Faculty, Medical University Tirana, 27-28 OCTOBER 2016 1 Transfusion-transmitted viral infections

More information

Anitha M.*, Sreedhar Babu K. V., Praveen M. D., Sriranjitha T. V. N.

Anitha M.*, Sreedhar Babu K. V., Praveen M. D., Sriranjitha T. V. N. International Journal of Research in Medical Sciences Anitha M et al. Int J Res Med Sci. 2017 Aug;5(8):3438-3442 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20173536

More information

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Jackson B R, Busch M P, Stramer S L, AuBuchon J P

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Jackson B R, Busch M P, Stramer S L, AuBuchon J P The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Jackson B R, Busch M P, Stramer S L, AuBuchon J P Record Status This is a critical abstract of an economic evaluation that meets

More information

HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings

HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings Elizabeth M. Dax with the staff of the National Serology Reference Laboratory, Australia My Background Worked in HIV

More information

Plasma for fractionation: South African Plasma Requirements

Plasma for fractionation: South African Plasma Requirements Plasma for fractionation: South African Plasma Requirements Dr Jeh-han Omarjee Head: Microbiological Sciences NBI is a "not for profit" company committed to providing safe, cost effective, quality medicinal

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Tested pathogen VIRAL Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recommended on national level Not

More information

NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY

NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA MINISTRY OF HEALTH NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY February 2005 Addis Ababa Ethiopia Acknowledgement The Ministry of Health of the Federal Democratic

More information

Source of effectiveness data Effectiveness data were derived from a single study combined with a review of previously completed studies.

Source of effectiveness data Effectiveness data were derived from a single study combined with a review of previously completed studies. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection Busch M P, Korelitz J J, Kleinman S H, Lee S R, Aubuchon J P, Schreiber

More information

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey This questionnaire consists of three sections: A. Collection and

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding on national level More stringent - recommended on national level Not legy binding and not recommended on

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding

More information

APPROACH TO RISK MANAGEMENT IN MEDICAL PRACTICE: STANDPOINT OF THE BLOOD TRASFUSION*

APPROACH TO RISK MANAGEMENT IN MEDICAL PRACTICE: STANDPOINT OF THE BLOOD TRASFUSION* 11 APPROACH TO RISK MANAGEMENT IN MEDICAL PRACTICE: STANDPOINT OF THE BLOOD TRASFUSION* Hisami IKEDA** Asian Med. J. 44(1): 11 21, 2000 Abstract: In the field of blood transfusion, risk management is defined

More information

Transfusion Transmissible Infections among Voluntary Blood Donors at the University Teaching Hospital, Lusaka, Zambia

Transfusion Transmissible Infections among Voluntary Blood Donors at the University Teaching Hospital, Lusaka, Zambia ORIGINAL ARTICLE Transfusion Transmissible Infections among Voluntary Blood Donors at the University Teaching Hospital, Lusaka, Zambia,2,3 2 3 3 D Chama, Y Ahmed, KS Baboo, H Halwindi, J Mulenga, 2 Zambia

More information

Guidance for Industry

Guidance for Industry Reprinted from FDA s website by EAS Consulting Group, LLC Guidance for Industry Recommendations for Screening, Testing, and Management of Blood Donors and Blood and Blood Components Based on Screening

More information

Plasma Fractionation Issues for Developing Countries DR YASMIN AYOB

Plasma Fractionation Issues for Developing Countries DR YASMIN AYOB Plasma Fractionation Issues for Developing Countries DR YASMIN AYOB Plasma Fractionation Evolved from a medical service to a global manufacturing industry Involves sophisticated industrial process High

More information

41st DIRECTING COUNCIL

41st DIRECTING COUNCIL PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 41st DIRECTING COUNCIL San Juan, Puerto Rico, 27 September-1 October 1999 Provisional Agenda Item 4.8 CD41/13 (Eng.) 19 July 1999 ORIGINAL: ENGLISH

More information

transfusion-transmissible HCV and HIV in Italy Haemovigilance and the residual risk of

transfusion-transmissible HCV and HIV in Italy Haemovigilance and the residual risk of Haemovigilance and the residual risk of transfusion-transmissible Giuliano Grazzini, MD National Blood Centre, National Institute of Health, Rome, Italy & International Federation of Blood Donor Organizations

More information

The testing of Donated Blood and Components at NHSBT

The testing of Donated Blood and Components at NHSBT The testing of Donated Blood and Components at NHSBT NHSBT is responsible for collecting all donated blood and platelets in England, then processing into components before issuing to client hospitals.

More information

seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north india

seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north india Indian J Med Res 142, September 2015, pp 317-322 DOI:1103/0971-5916.166598 seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north india R.N. Makroo,

More information

2014/LSIF/PD/030 Risk Assessment and Cost-Effectiveness of Blood Safety Interventions for HIV, HCV, and HBV Development of a Web-Based Application

2014/LSIF/PD/030 Risk Assessment and Cost-Effectiveness of Blood Safety Interventions for HIV, HCV, and HBV Development of a Web-Based Application 2014/LSIF/PD/030 Risk Assessment and Cost-Effectiveness of Blood Safety Interventions for HIV, HCV, and HBV Development of a Web-Based Application Submitted by: Blood Systems Research Institute (BSRI)

More information

Cataloguing-in-Publication (CIP) data. CIP data are available at

Cataloguing-in-Publication (CIP) data. CIP data are available at Blood Transfusion Services in South-East Asia Region. A 5-year review ISBN: 978-92-9022-651-2 World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike

More information

Research Article Decreasing Prevalence of Transfusion Transmitted Infection in Indian Scenario

Research Article Decreasing Prevalence of Transfusion Transmitted Infection in Indian Scenario e Scientific World Journal, Article ID 173939, 4 pages http://dx.doi.org/10.1155/2014/173939 Research Article Decreasing Prevalence of Transfusion Transmitted Infection in Indian Scenario Tulika Chandra,

More information

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Version for the Silent Procedure 29 April Agenda item January Hepatitis Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh

More information

WHO/EHT/ Global Database on Blood Safety

WHO/EHT/ Global Database on Blood Safety WHO/EHT/4.9 Global Database on Blood Safety Report 21 22 Needs and challenges The need for a safe and adequate blood supply is universal. In countries with developed health care systems, blood and blood

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately

More information

Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India.

Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India. Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India. Cinzia Keechilot, Veena Shenoy 1,V Anil kumar 2,Lalita Biswas 3. MBBS student * Transfusion

More information

to be notified: all parties involved in the graduated plan procedure. Annexes

to be notified: all parties involved in the graduated plan procedure. Annexes Paul-Ehrlich-Institut Postfach 63207 Langen, Germany To all marketing authorisation holders of cellular blood preparations and therapeutic single plasmas as well as authorisation holders of stem cells

More information

Guidance for Industry

Guidance for Industry Reprinted from FDA s website by Guidance for Industry Recommendations for Screening, Testing, and Management of Blood Donors and Blood and Blood Components Based on Screening Tests for Syphilis DRAFT GUIDANCE

More information

Probability of false initial and repeat ID-NAT reactive donations. Marion Vermeulen IPFA Rome 2014

Probability of false initial and repeat ID-NAT reactive donations. Marion Vermeulen IPFA Rome 2014 Probability of false initial and repeat ID-NAT reactive donations Marion Vermeulen IPFA Rome 2014 Overview of SANBS SANBS is a non profit organization Provides a vein to vein blood transfusion service

More information

NEWS BK NEWS # 378 /MKT DATE : TITLE. Dear colleagues,

NEWS BK NEWS # 378 /MKT DATE : TITLE. Dear colleagues, 1 NEWS BK NEWS # 378 /MKT DATE : 16022016 TITLE : New Bioelisa reagents Brochures Dear colleagues, We are pleased to present the new Bioelisa reagents Brochures, which are a very useful marketing and selling

More information

Maximizing Cornea and Tissue Donation through Specimen Quality

Maximizing Cornea and Tissue Donation through Specimen Quality Maximizing Cornea and Tissue Donation through Specimen Quality Robert W. Bresler, Sydney D. Gastreich, Elias G. Koulouriotis, Linda S. Martin, Susan Diane Brockmeier, Chak-Sum Ho, PhD Abstract Purpose:

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC and its technical Directives (particularly 2006/17/EC) More stringent -legally binding, applies for all donations and all donor profiles

More information

QUALITY CONTROL Infectious Disease

QUALITY CONTROL Infectious Disease QUALITY CONTROL Infectious Disease 1 Infectious Disease Quality Control The human based material used in the production of our Quality Controls is sourced from the Taiwan Blood Services Foundation (TBSF).

More information

Confirmatory Testing Algorithm. Routine Donor Testing Algorithm

Confirmatory Testing Algorithm. Routine Donor Testing Algorithm Confirmatory Testing Algorithm Blood Confirmatory ABO/Rh Beckman Coulter PK-ABO/Rh Immucor NEO ABO/Rh Immucor NEO ABO/Rh Immucor Manual ABO/Rh Typing Immucor Manual ABO/Rh Typing Discrepancy Resolution

More information

June 8, Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852

June 8, Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852 June 8, 2018 Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Submitted via http://www.regulations.gov Re: Docket No. FDA 2016 D 0545,

More information

WHO Prequalification of In Vitro Diagnostics Programme

WHO Prequalification of In Vitro Diagnostics Programme WHO Prequalification of In Vitro Diagnostics Programme International HIV/Viral Hepatitis Co-Infection Satellite Meeting 19 July 2014, Melbourne Anita Sands Prequalification Diagnostics Team Department

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Non-reproductive tissues and cells VIRAL

More information

Duration: 12 months May to April

Duration: 12 months May to April SPECIALIST CERTIFICATE IN TRANSFUSION SCIENCE PRACTICE PROGRAMME OF STUDY OVERVIEW Example only Duration: 12 months May to April This document serves as a general programme overview only. To ensure you

More information

Source Plasma Safety

Source Plasma Safety Source Plasma Safety Plasma May 15-19, 2017 George Schreiber, ScD, PPTA Director, Epidemiology Three components: Plasma Product Safety Donor Quality Manufacturing Pool Quality Fractionation Process Safe

More information

The use of QCMD proficiency testing panels in clinical virology.

The use of QCMD proficiency testing panels in clinical virology. The use of QCMD proficiency testing panels in clinical virology. Prof.dr. Bert Niesters Department of Medical Microbiology Division of Clinical Virology UMC Groningen Disease Disease Management Viral Load

More information

Cap Laboratory Accreditation Manual Appendix B

Cap Laboratory Accreditation Manual Appendix B Cap Laboratory Accreditation Manual Appendix B Appendix B Environmental Holding Times. 144 Screening Manual: A Guide for Health Departments and Providers. (Sept. 2013). Critical bottle with the water sample

More information

Playing Detective: going in search of the source of infection. Su Brailsford Consultant in Epidemiology and Health Protection

Playing Detective: going in search of the source of infection. Su Brailsford Consultant in Epidemiology and Health Protection Playing Detective: going in search of the source of infection Su Brailsford Consultant in Epidemiology and Health Protection The Micro Services clinical team Are inquisitive Like problem solving Don t

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Schedule of Accreditation 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK National Infection Service, Public Health England Colindale 61 Colindale Avenue London NW9 5EQ Contact: Dr Sanjiv

More information

The Alphabet Soup of Viral Hepatitis Testing

The Alphabet Soup of Viral Hepatitis Testing The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,

More information

NAT Screening of Blood Donations in NBC, TRCS

NAT Screening of Blood Donations in NBC, TRCS IPFA/PEI, Italy NAT Screening of Blood Donations in NBC, TRCS 2000-2001 Clinical evaluation using COBAS AmpliiScreen HIV & HCV assays, (MP24) window period rate - 1 : 108,768 for HIV-1 and HCV 2002 Routine

More information

Impact of multi-dye multiplex technology on testing algorithm

Impact of multi-dye multiplex technology on testing algorithm Impact of multi-dye multiplex technology on testing algorithm Lydia Blanco. Mª Isabel Gonzalez-Fraile Centro de Hemoterapia y Hemodonación de Castilla y León, España TTI EPIDEMIOLOGICAL DATA IN SPAIN NAT

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Adequate and Appropriate Donor Screening Tests for Hepatitis B; Hepatitis B Surface Antigen (HBsAg) Assays Used to Test Donors of Whole Blood and Blood Components, Including Source

More information

Clinical Application of New Treponemal Antibody Test in Blood Donors

Clinical Application of New Treponemal Antibody Test in Blood Donors Clinical Application of New Treponemal Antibody Test in Blood Donors Parichart Permpikul, MD Department of Transfusion Medicine Faculty of Medicine Siriraj Hospital Mahidol University Bangkok, Thailand

More information

1. Third year resident, MD IHBT, 2. Senior Professor, Department of IHTM, 3. Second year resident, MD IHBT, SMS Medical College and Hospital, Jaipur

1. Third year resident, MD IHBT, 2. Senior Professor, Department of IHTM, 3. Second year resident, MD IHBT, SMS Medical College and Hospital, Jaipur www.ijmse.com International Journal of Medical Science and Education An official Publication of Association for Scientific and Medical Education (ASME) Original Research Article pissn- 2348 4438 eissn-2349-3208

More information

Khalid Alquthami (Correspondence) Regional Lab, Makkah. Saudi Arabia

Khalid Alquthami (Correspondence) Regional Lab, Makkah. Saudi Arabia 1 Regional Lab, Makkah. Saudi Arabia stract: Clinical specificity and genotype/subtype detection of viruses using the Cobas TaqScreen MPX system V 2.0, which is a nucleic acid test (NAT) that uses multiples

More information

SPEECH BY THE GUEST OF HONOUR HONOURABLE MINISTER OF HEALTH & CHILD CARE HON. DR DAVID PARIRENYATWA (SENATOR) NATIONAL COMMEMORATION

SPEECH BY THE GUEST OF HONOUR HONOURABLE MINISTER OF HEALTH & CHILD CARE HON. DR DAVID PARIRENYATWA (SENATOR) NATIONAL COMMEMORATION SPEECH BY THE GUEST OF HONOUR HONOURABLE MINISTER OF HEALTH & CHILD CARE HON. DR DAVID PARIRENYATWA (SENATOR) AT THE WORLD BLOOD DONOR DAY NATIONAL COMMEMORATION BULAWAYO METROPOLITAN PROVINCE 13 JUNE

More information

Tania Paarman Western Province Blood Transfusion Service (WPBTS), Cape Town, South Africa

Tania Paarman Western Province Blood Transfusion Service (WPBTS), Cape Town, South Africa THERAPEUTIC PHLEBOTOMY AND BLOOD DONATION IN PATIENTS WITH HEREDITARY HAEMOCHROMATOSIS AND ERYTHROCYTOSIS: A 15 YEAR REVIEW IN THE WESTERN CAPE REGION OF SOUTH AFRICA Tania Paarman Western Province Blood

More information

Single donator specimens as advantage in external quality control assessments of infectious diseases

Single donator specimens as advantage in external quality control assessments of infectious diseases Single donator specimens as advantage in external quality control assessments of infectious diseases MD, PhD Maija Lappalainen and MD Jukka Suni HUSLAB, Department of Virology Labquality Days 10.2.2007

More information

TANZANIA NATIONAL STRATEGIC PLAN FOR CONTROL OF VIRAL HEPATITIS

TANZANIA NATIONAL STRATEGIC PLAN FOR CONTROL OF VIRAL HEPATITIS TANZANIA NATIONAL STRATEGIC PLAN FOR CONTROL OF VIRAL HEPATITIS 2017-2021 A Draft ANGELINA C. SIJAONA THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH, COMMUNITY DEVELOPMENT, GENDER, ELDERLY AND CHILDREN

More information

UGANDA POPULATION-BASED HIV IMPACT ASSESSMENT UPHIA

UGANDA POPULATION-BASED HIV IMPACT ASSESSMENT UPHIA EXTENDED SUMMARY SHEET: PRELIMINARY FINDINGS APRIL 018 UGANDA POPULATION-BASED HIV IMPACT ASSESSMENT UPHIA 016 017 The Uganda Population-based HIV Impact Assessment (UPHIA), a household-based national

More information

Serological screening for syphilis in HIV-infected individuals: is a non-treponemal test adequate in the era of increasing of new syphilis infections?

Serological screening for syphilis in HIV-infected individuals: is a non-treponemal test adequate in the era of increasing of new syphilis infections? Abstract no. WEPE 494 Serological screening for syphilis in HIV-infected individuals: is a non-treponemal test adequate in the era of increasing of new syphilis infections? G.Chrysos 1, D.Karageorgopoulos

More information

The Technical Aspects of Pathogen Testing in Canada. Nancy Angus Canadian Blood Services Director, Testing

The Technical Aspects of Pathogen Testing in Canada. Nancy Angus Canadian Blood Services Director, Testing PERMISSON TO USE: Please note that, by making their presentations available on-line, primary authors have agreed to share their presentations. However, should you want to use some of the data or slides

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recomd on national level Not legy binding and not recomd

More information

HIV/AIDS and ART Registry of the Philippines (HARP)

HIV/AIDS and ART Registry of the Philippines (HARP) HIV/AIDS and ART Registry of the Philippines (HARP) Number of Cases Department of Health Epidemiology Bureau FEBRUARY 215 28 21 212 214 215 Number of Newly Diagnosed with HIV per day: 1 4 9 17 2 NEWLY

More information

For information only: all participants in the graduated plan procedure. 7 January 2013

For information only: all participants in the graduated plan procedure. 7 January 2013 Paul-Ehrlich-Institut P.O. Box 63207 Langen, Germany To: All marketing authorisation holders of cellular blood products and therapeutic single plasma as well as holders of an authorisation for stem cells

More information

2019 HIV Diagnostics Conference March 27, 2019

2019 HIV Diagnostics Conference March 27, 2019 2019 HIV Diagnostics Conference March 27, 2019 Performance of the Syphilis Reverse Algorithm Using the Abbott Architect Syphilis TP (ASTP) and its Role in a Blended Diagnostic Application in Florida s

More information

FDA Reentry Guidance

FDA Reentry Guidance FDA Reentry Guidance T. cruzi - Chagas, Hepatitis C and HIV Wednesday 6/6/18 Doug Denyer O Dina Hurlburt, SBB(ASCP)CM Outline Impact to Clients Review of FDA Guidance Documents Reentry Request Process

More information

UK Standards for Microbiology Investigations

UK Standards for Microbiology Investigations UK Standards for Microbiology Investigations Blood Borne Virus Testing in Dialysis Patients Issued by the Standards Unit, Microbiology Services, PHE Virology V 10 Issue no: 2 Issue date: 27.04.15 Page:

More information

Blood Screening. Technology Opportunity Assessment. Prepared for the Merck for Mothers Program. February

Blood Screening. Technology Opportunity Assessment. Prepared for the Merck for Mothers Program. February February 2012 Blood Screening Technology Opportunity Assessment Prepared for the Merck for Mothers Program MAILING ADDRESS PO Box 900922 Seattle, WA 98109 USA ADDRESS 2201 Westlake Avenue Suite 200 Seattle,

More information

Documentation, Codebook, and Frequencies

Documentation, Codebook, and Frequencies 2 Documentation, Codebook, and Frequencies Laboratory Component: Hepatitis B: core antibody, surface antibody and surface antigen; Hepatitis C: confirmed antibody; Hepatitis D antibody Survey Years: 2003

More information

HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME

HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME Technical considerations and case definitions for VIRAL HEPATITIS SURVEILLANCE Dr Yvan J-F Hutin Global Hepatitis Programme 01 FOUR MAIN HEPATITIS VIRUSES

More information

Targeting HIV Settings Through PEPFAR. Bill Coggin, OGAC PEPFAR Laboratory Technical Working Group

Targeting HIV Settings Through PEPFAR. Bill Coggin, OGAC PEPFAR Laboratory Technical Working Group Targeting HIV Settings Through PEPFAR Bill Coggin, OGAC PEPFAR Laboratory Technical Working Group PEPFAR Laboratory Program is a Critical part of Health Systems Strengthening Mission: To support countries

More information

Cronicon BACTERIOLOGY AND VIROLOGY RESEARCH

Cronicon BACTERIOLOGY AND VIROLOGY RESEARCH Cronicon OPEN ACCESS BACTEIOLOGY AND IOLOGY ESEACH esearch Article The Trend of Transfusion Transmitted Infections among the Blood Donors in Five Years; With Special Focus on educing the HI Transmission

More information

Direct Comparison of the Traditional and Reverse Syphilis Screening Algorithms

Direct Comparison of the Traditional and Reverse Syphilis Screening Algorithms JCM Accepts, published online ahead of print on 16 November 2011 J. Clin. Microbiol. doi:10.1128/jcm.05636-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All

More information

Primary Sample Manual Infectious Serology Issue No Effective Date: 20/09/17 Page 1 of 15 EUROFINS BIOMNIS

Primary Sample Manual Infectious Serology Issue No Effective Date: 20/09/17 Page 1 of 15 EUROFINS BIOMNIS Issue No. 2.02 Effective Date: 20/09/17 Page 1 of 15 Written / Revised By: Dr. Mike Louw, Medical Director Date: Reviewed By: Date: Dr. Sinead Kelly, Infectious Serology Consultant Authorised By: Jean-Sébastien

More information

WHO Guidelines on hepatitis B and C testing

WHO Guidelines on hepatitis B and C testing WHO Guidelines on hepatitis B and C testing Dr. Philippa Easterbrook Global Hepatitis Programme World Hepatitis Summit Nov 2017 Sao Paulo, Brazil Outline of presentation Key recommendations of 2017 WHO

More information

WORLD HEALTH ORGANIZATION. Blood safety: proposal to establish World Blood Donor Day

WORLD HEALTH ORGANIZATION. Blood safety: proposal to establish World Blood Donor Day WORLD HEALTH ORGANIZATION EXECUTIVE BOARD EB115/9 115th Session 25 November 2004 Provisional agenda item 4.6 Blood safety: proposal to establish World Blood Donor Day Report by the Secretariat 1. Blood

More information